Research scientists at a small biotech firm are investigating new methods of controlling the growth and...
Research scientists at a small biotech firm are investigating new methods of controlling the growth and metastasis of malignant cells in patients diagnosed with breast cancer. They have developed a novel peptide-based drug, potentially deliverable therapeutically, that disrupts the tumor cells' ability to adhere to the ECM, which in turn triggers apoptosis. Which of the following is a most likely target of such drugs? Cadherins Fibrillin Integrins Adhesins Glycolipids of the cell membrane